Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIIP versus preprandial insulin lispro in insulin-naive adults with type 2 diabetes
2005-004747-64Phase 3Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of insulin human and human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Mean change in HbA1c from baseline at 6 months. Started Dec 2005; status: terminated.
02
Drugs
insulin humanhuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-004747-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004747-64.